Cargando…

A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease

BACKGROUND: Stenosis, fistulization, and perforation of the bowel are severe outcomes which can occur in patients with Crohn’s disease. Accurate prediction of these events may enable clinicians to alter treatment strategies and avoid these outcomes. AIMS: To study the correlation between longitudina...

Descripción completa

Detalles Bibliográficos
Autores principales: Irwin, James, Lord, Anton, Ferguson, Emma, Simms, Lisa A., Hanigan, Katherine, Montoya, Carlos A., Radford-Smith, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905172/
https://www.ncbi.nlm.nih.gov/pubmed/36125595
http://dx.doi.org/10.1007/s10620-022-07639-w
_version_ 1784883776221872128
author Irwin, James
Lord, Anton
Ferguson, Emma
Simms, Lisa A.
Hanigan, Katherine
Montoya, Carlos A.
Radford-Smith, Graham
author_facet Irwin, James
Lord, Anton
Ferguson, Emma
Simms, Lisa A.
Hanigan, Katherine
Montoya, Carlos A.
Radford-Smith, Graham
author_sort Irwin, James
collection PubMed
description BACKGROUND: Stenosis, fistulization, and perforation of the bowel are severe outcomes which can occur in patients with Crohn’s disease. Accurate prediction of these events may enable clinicians to alter treatment strategies and avoid these outcomes. AIMS: To study the correlation between longitudinal laboratory testing and subsequent intestinal complications in patients with Crohn’s disease. METHODS: An observational cohort of patients with Crohn’s disease at a single center were analyzed between 01/01/1994 and 06/30/2016. A complication was defined as the development of an intestinal fistula, stenosis, or perforation. Exploratory analysis using Cox regression was performed to select the best statistical method to represent longitudinal laboratory data. Cox regression was used to identify laboratory variables independently associated with the development of a subsequent complication. A clinical scoring tool was designed. RESULTS: In 246 patients observed over a median of 5.72 years, 134 complications occurred. Minimum or maximum value in a preceding window period of one year was most strongly associated with subsequent complication. A Longitudinal Laboratory score of ≥ 2 (maximum albumin level < 39 g/L = 1, maximum mean cell volume < 88 fL = 1, minimum platelet count > 355 × 10(9)/L = 1, minimum C reactive protein > 5 mg/L = 1) was 62% sensitive and 91% specific in identifying patients who develop a subsequent complication. CONCLUSION: A consistent reduction in serum albumin and mean cell volume, and a consistent increase in platelet count and C reactive protein were associated with a subsequent complication in patients with Crohn’s disease. Longitudinal laboratory tests may be used as described in this paper to provide a rational for earlier escalation of therapy.
format Online
Article
Text
id pubmed-9905172
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-99051722023-02-08 A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease Irwin, James Lord, Anton Ferguson, Emma Simms, Lisa A. Hanigan, Katherine Montoya, Carlos A. Radford-Smith, Graham Dig Dis Sci Original Article BACKGROUND: Stenosis, fistulization, and perforation of the bowel are severe outcomes which can occur in patients with Crohn’s disease. Accurate prediction of these events may enable clinicians to alter treatment strategies and avoid these outcomes. AIMS: To study the correlation between longitudinal laboratory testing and subsequent intestinal complications in patients with Crohn’s disease. METHODS: An observational cohort of patients with Crohn’s disease at a single center were analyzed between 01/01/1994 and 06/30/2016. A complication was defined as the development of an intestinal fistula, stenosis, or perforation. Exploratory analysis using Cox regression was performed to select the best statistical method to represent longitudinal laboratory data. Cox regression was used to identify laboratory variables independently associated with the development of a subsequent complication. A clinical scoring tool was designed. RESULTS: In 246 patients observed over a median of 5.72 years, 134 complications occurred. Minimum or maximum value in a preceding window period of one year was most strongly associated with subsequent complication. A Longitudinal Laboratory score of ≥ 2 (maximum albumin level < 39 g/L = 1, maximum mean cell volume < 88 fL = 1, minimum platelet count > 355 × 10(9)/L = 1, minimum C reactive protein > 5 mg/L = 1) was 62% sensitive and 91% specific in identifying patients who develop a subsequent complication. CONCLUSION: A consistent reduction in serum albumin and mean cell volume, and a consistent increase in platelet count and C reactive protein were associated with a subsequent complication in patients with Crohn’s disease. Longitudinal laboratory tests may be used as described in this paper to provide a rational for earlier escalation of therapy. Springer US 2022-09-20 2023 /pmc/articles/PMC9905172/ /pubmed/36125595 http://dx.doi.org/10.1007/s10620-022-07639-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Article
Irwin, James
Lord, Anton
Ferguson, Emma
Simms, Lisa A.
Hanigan, Katherine
Montoya, Carlos A.
Radford-Smith, Graham
A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
title A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
title_full A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
title_fullStr A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
title_full_unstemmed A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
title_short A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
title_sort method using longitudinal laboratory data to predict future intestinal complication in patients with crohn’s disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905172/
https://www.ncbi.nlm.nih.gov/pubmed/36125595
http://dx.doi.org/10.1007/s10620-022-07639-w
work_keys_str_mv AT irwinjames amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT lordanton amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT fergusonemma amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT simmslisaa amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT hanigankatherine amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT montoyacarlosa amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT radfordsmithgraham amethodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT irwinjames methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT lordanton methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT fergusonemma methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT simmslisaa methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT hanigankatherine methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT montoyacarlosa methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease
AT radfordsmithgraham methodusinglongitudinallaboratorydatatopredictfutureintestinalcomplicationinpatientswithcrohnsdisease